Yamada Hirohide, Kawano Takashi, Tanaka Katsuya, Yasui Sonoko, Mawatari Kazuaki, Takahashi Akira, Nakaya Yutaka, Oshita Shuzo
Department of Anesthesiology, Tokushima University School of Medicine, 3-18-15 Kuramoto, Tokushima, 770-8503, Japan.
J Anesth. 2007;21(4):472-9. doi: 10.1007/s00540-007-0551-9. Epub 2007 Nov 1.
Propofol inhibits adenosine triphosphate-sensitive potassium (K(ATP)) channels, which may result in the blocking of ischemic preconditioning in the heart. During cardiac ischemia, sarcolemmal K(ATP) channel activity is regulated by the increased levels of cytosolic metabolites, such as adenosine diphosphate (ADP) and protons. However, it remains unclear whether these cytosolic metabolites modulate the inhibitory action of propofol. The aim of this study was to investigate the effects of intracellular MgADP and acidification on K(ATP) channel inhibition by propofol.
We used inside-out patch-clamp configurations to investigate the effects of propofol on the activities of recombinant cardiac sarcolemmal K(ATP) channels, which are reassociated by expressed subunits, sulfonylurea receptor (SUR) 2A, and inwardly rectifying potassium channels (Kir6.2).
In the absence of MgADP, propofol inhibited the SUR2A/Kir6.2 channel currents in a concentration-dependent manner, and an IC(50) of 78 microM. Increasing the intracellular MgADP concentrations to 0.1 and 0.3 mM markedly attenuated the inhibitory potency of propofol, and shifted the IC(50) to 183 and 265 microM, respectively. Moreover, decreasing the intracellular pH from 7.4 to 6.5 attenuated the inhibitory potency of propofol, and shifted the IC(50) to 277 microM. In addition, propofol-induced inhibition of truncated Kir6.2DeltaC36 currents, which form a functional channel without SUR2A, was not affected by an increase in intracellular MgADP. However, intracellular acidification (pH 6.5) significantly reduced the propofol sensitivity of Kir6.2DeltaC36 channels.
Our results demonstrated that the existence of intracellular MgADP and protons attenuated the direct inhibitory potency of propofol on recombinant cardiac sarcolemmal K(ATP) channels, via SUR2A and Kir6.2 subunits, respectively.
丙泊酚可抑制三磷酸腺苷敏感性钾(K(ATP))通道,这可能导致心脏缺血预处理被阻断。在心脏缺血期间,肌膜K(ATP)通道活性受胞质代谢产物水平升高的调节,如二磷酸腺苷(ADP)和质子。然而,这些胞质代谢产物是否调节丙泊酚的抑制作用仍不清楚。本研究的目的是探讨细胞内MgADP和酸化对丙泊酚抑制K(ATP)通道的影响。
我们采用内向外膜片钳配置,研究丙泊酚对重组心脏肌膜K(ATP)通道活性的影响,该通道由表达的亚基磺脲类受体(SUR)2A和内向整流钾通道(Kir6.2)重新组装而成。
在不存在MgADP的情况下,丙泊酚以浓度依赖性方式抑制SUR2A/Kir6.2通道电流,半数抑制浓度(IC(50))为78微摩尔。将细胞内MgADP浓度增加到0.1和0.3毫摩尔显著减弱了丙泊酚的抑制效力,使IC(50)分别变为183和265微摩尔。此外,将细胞内pH从7.4降至6.5减弱了丙泊酚的抑制效力,使IC(50)变为277微摩尔。另外,丙泊酚诱导的对截短的Kir6.2DeltaC36电流的抑制(该电流形成无SUR2A的功能性通道)不受细胞内MgADP增加的影响。然而,细胞内酸化(pH 6.5)显著降低了Kir6.2DeltaC36通道对丙泊酚的敏感性。
我们的结果表明,细胞内MgADP和质子的存在分别通过SUR2A和Kir6.2亚基减弱了丙泊酚对重组心脏肌膜K(ATP)通道的直接抑制效力。